Rep. Kevin Hern (R-OK) Sells MRSH Stock

Oklahoma Congressman Kevin Hern sold shares of Marsh & McLennan valued between $50,001 and $100,000.

Reviewed by automated data checks against the source filing. How we make and check alerts

Rep. Kevin Hern (R-OK) sold between $50,001 and $100,000 of Marsh & McLennan Companies, Inc. ($MRSH) stock on September 23, 2026. The trade was disclosed in a STOCK Act periodic transaction report filed October 13, 2026.

Since the trade, $MRSH is up 0.2% after 1 week and up 11.2% to date (from the $169.39 close on Sep 23, 2026).

View the original STOCK Act disclosure (House Clerk)

Kevin Hern

Financial Disclosure Report

Clerk of the House of Representatives • Legislative Resource Center • B81 Cannon Building • Washington, DC 20515

Filer Information

Name:
Rep. Kevin Hern (R-OK)
Status:
Member — House
State/District:
OK-1
Party:
Republican

Filing Information

Filing Type:
Periodic Transaction Report
Filing Year:
2026
Filing Date:
Oct 13, 2026

Schedule B: Transactions

AssetTransactionDateAmount
Marsh & McLennan Companies, Inc. ($MRSH) Sell Sep 23, 2026 $50,001 - $100,000

Summary of the filed report, not the original document. View the original: STOCK Act disclosure (House Clerk)

MRSH Marsh & McLennan Companies, Inc.
$188.35 +5.48% year to date
Daily close · Oct 16, 2026

Key Points

  • On September 23, 2026, Rep. Kevin Hern sold shares of Marsh & McLennan Companies (MRSH) valued between $50,001 and $100,000.
  • The stock recently traded around $188.36, which is above its 50-day and 200-day moving averages by 3.9% and 6.6%, respectively.
  • Analysts have mixed views on the stock, with a consensus target price of $202.52, indicating it trades below this target.

Get $MRSH trade alerts by text

We text you when insiders, Congress or big funds trade $MRSH. Free.

Not investment advice. EarningsIQ is not a registered investment adviser, and this automated Marsh & McLennan Companies, Inc. alert may contain errors. Disclosures

Oklahoma Congressman Kevin Hern sold shares of Marsh & McLennan Companies, Inc. (MRSH) on September 23, 2026. The sale was valued between $50,001 and $100,000, according to a periodic transaction report filed under the STOCK Act on October 13, 2026.

Congressional trading track record

Kevin Hern vs. the S&P 500

YTD return +5.88% hypothetical
All-time return +5.88% S&P 500 -0.32%
vs. S&P 500 +6.20% ahead of the index

Hypothetical returns from Kevin Hern's disclosed trades, not real profit or advice. How we model this.

Inside Kevin Hern's Trade

Kevin Hern's recent sale of Marsh & McLennan shares reflects a strategic adjustment in his portfolio. This transaction adds to his previous sales of stocks from other companies, including TJX Companies and Starbucks, both made on September 2, 2026.

Other Institutional Activity in Marsh & McLennan

Several other institutional investors have adjusted their positions in Marsh & McLennan. Blackrock Inc. trimmed its stake by 2,561,681 shares, leaving it with 39,502,046 shares worth about $7.44 billion. Vanguard Capital Management LLC added 6,293 shares, bringing its total to 31,472,575 shares valued at approximately $5.93 billion. State Street Corporation increased its holdings by 331,059 shares, ending with 22,401,676 shares valued at around $4.22 billion. Meanwhile, Capital World Investors added 152,742 shares for a total of 18,122,340 shares worth about $3.41 billion. Wellington Management Group reduced its stake by 396,066 shares, now holding 16,975,238 shares valued at about $3.20 billion.

Marsh & McLennan Companies, Inc. Stock Up 1.0%

Marsh & McLennan shares are currently trading at $188.36, which is above both the 50-day moving average of $181.38 and the 200-day moving average of $176.70. However, the stock is about 5.1% below its 52-week high of $198.49. The recent price is also 7% below the mean target price of $202.52 set by analysts.

Recent Earnings

In its most recent financial performance, Marsh & McLennan reported trailing twelve-month revenue of approximately $28.46 billion, with an earnings per share (EPS) of $8.18. The company has shown a revenue growth of 8.1% year-over-year and maintains a net margin of 14.2%. The next earnings report is scheduled for January 28, 2027.

Dividend

Marsh & McLennan pays an annual dividend of $3.96 per share, which translates to a yield of 2.12%. The company's dividend payout ratio stands at 44.1%, indicating a balanced approach to returning value to shareholders while retaining earnings for growth.

Insider Buying and Selling at Marsh & McLennan Companies, Inc.

Several insiders have sold shares of Marsh & McLennan recently. Chief Executive Officer John Q Doyle sold 16,656 shares on September 2, 2026, at an average price of $188.51, totaling about $3.14 million. Other insiders, including Chief Technology Officer Paul Beswick and General Counsel Katherine J. Brennan, also sold shares in previous months, reflecting a broader trend of insider selling.

Analysts Set New Price Targets

On October 1, 2026, JP Morgan maintained its Overweight rating on Marsh & McLennan with a price target of $215.00. Morgan Stanley, however, adjusted its target down to $180.00 on October 6, 2026, while maintaining an Equal-Weight rating. UBS also maintained a Buy rating with a target of $222.00 on the same date. Overall, analysts have a consensus recommendation of Hold with a mean target price of $202.52.

About Marsh & McLennan

Marsh & McLennan Companies, Inc. is a professional services firm that offers advisory services and insurance solutions globally. The company operates through various segments, including Risk and Insurance Services and Consulting, helping clients manage risk and develop strategic solutions. This diverse portfolio positions Marsh & McLennan as a key player in the financial services sector, which is vital for many businesses.

Bottom Line

Investors will be watching Marsh & McLennan closely as the company approaches its next earnings report on January 28, 2027. With mixed analyst opinions and recent insider activity, there may be more developments to follow regarding the stock's performance and investor sentiment.

Source: Kevin Hern's STOCK Act disclosure on $MRSH (Sep 23, 2026). Read the original filing: STOCK Act disclosure (House Clerk). Written by software, not financial advice. How we make alerts

Get $MRSH trade alerts by text